Monopar Therapeutics Inc. (MNPR) - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the Annual Meeting of Stockholders held by Monopar Therapeutics Inc. on June 22, 2026. The record date for the meeting was April 27, 2026. The filing details the voting results for four proposals submitted to security holders.
Key Financial Metrics
This filing is a Current Report regarding corporate governance and does not contain financial statements. Consequently, data regarding revenue, profit, cash flow, margins, debt, and liquidity is not provided in this document.
Material Changes and Voting Results
A total of 6,698,778 shares were entitled to vote, with 5,760,392 shares represented at the meeting. All four proposals were approved by stockholders:
- Proposal 1 (Election of Directors): Six directors were elected. Nicole Sweeny received the highest "For" vote count (4,911,758), while Christopher M. Starr, Ph.D. received the lowest (4,203,485). All candidates received a majority of votes cast.
- Proposal 2 (Executive Compensation): Stockholders approved the compensation of Named Executive Officers (NEOs) on an advisory basis with 4,355,628 votes "For" and 604,858 "Against".
- Proposal 3 (2026 Stock Incentive Plan): The plan was approved with 4,444,209 votes "For" and 516,570 "Against".
- Proposal 4 (Auditor Ratification): BPM LLP was ratified as the independent registered public accounting firm for the year ending December 31, 2026, with 5,759,198 votes "For" and only 998 "Against".
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, or specific risk factors. The document is limited to the procedural results of the Annual Meeting.
Key Facts for Investor Verification
- Verify the full composition of the newly elected Board of Directors and their tenure terms.
- Review the details of the approved 2026 Stock Incentive Plan to understand potential dilution and grant limits.
- Confirm the engagement letter and audit scope with BPM LLP for the fiscal year ending December 31, 2026.
- Check the company's most recent 10-K or 10-Q for financial performance data, as this 8-K contains no financial metrics.